Trail receptors 1 and 2 map to chromosome 8p21-22 frequently lost in tumours and mutations of trail receptors have been described in up to 20% of various human tumours, including breast cancer, head and neck cancers, and non-Hodgkin lymphomas. This evidence concerns the gene TNFRSF10A and neoplasm.